27
total announcements
NATCAPSUQ.NS · 15 min delayed
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange about the completion of dispatch of Corrigendum Notice of Extraordinary General Meeting (EGM) through newspaper publication.
Natural Capsules Limited
Natural Capsules Limited has issued a corrigendum to the notice of its Extra-Ordinary General Meeting (EGM) to incorporate changes in the issue price and quantity of Equity Shares and Convertible Warrants proposed to be issued on a preferential basis.
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange regarding Outcome of Board Meeting held on September 02, 2026, where the Board approved the Revised Price and Quantity of Equity Shares and Convertible Warrants of Preferential Issue, and the issuance of 4,50,000 Convertible Warrants to the promoter/promoter group at an issue price of ₹178.
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange about Copy of Newspaper Publication
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange about a copy of newspaper publication regarding an Extraordinary General Meeting to be held on September 09, 2026.
Natural Capsules Limited
Natural Capsules Limited has announced a record date of September 2nd, 2026, for the purpose of an Extraordinary General Meeting (EGM) scheduled on September 9th, 2026.
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on September 09, 2026, to consider issuance of equity shares on a preferential basis to Mr. Sunil Laxminarayan Mundra, a promoter, for Rs. 2 crores.
Natural Capsules Limited
Natural Capsules Limited has informed about the resignation of Mr. Pramod Kasat as Independent Director of its Material Unlisted Subsidiary, Natural Biogenex Private Limited, with effect from August 17, 2026.
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange about the publication of unaudited financial results for the quarter ended June 30, 2026, in Business Line and Sanjevani newspapers.
Natural Capsules Limited
Natural Capsules Limited has submitted the Exchange a copy Scrutinizer's report of Annual General Meeting held on August 12, 2026. The company has informed the Exchange regarding voting results.
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange about Investor Presentation, enclosing the copy of investor presentation in connection with the Unaudited Consolidated & Standalone Financial Results for quarter ended June 30, 2026.
Natural Capsules Limited
Natural Capsules Limited has announced its financial results for the quarter ended June 30, 2026, with revenue of ₹4871 Cr, EBITDA of ₹1.12 Cr, and EBITDA margins of 2.30%. PAT was ₹5.74Cr, with a 15% increase YoY.
Natural Capsules Limited
Natural Capsules Limited has informed about the appointment of Mr. K. H. Honneshaiah as the new Chief Operating Officer of its Material Unlisted Subsidiary, Natural Biogenex Private Limited.
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange regarding Outcome of Board Meeting held on August 12, 2026. The Board of Directors approved the Unaudited Consolidated & Standalone Financial Results for the Quarter ended June 30, 2026, and also approved the preferential issue of up to 1,25,000 equity shares and 5,00,000 convertible warrants to the promoter/promoter group at an issue price of ₹160 per equity share.
Natural Capsules Limited
Natural Capsules Limited has submitted its financial results for the period ended June 30, 2026. The company's board of directors has approved the unaudited consolidated and standalone financial results. Additionally, the board has approved a preferential issue of up to 1,25,000 equity shares and 5,00,000 convertible warrants to the promoter/promoter group at an issue price of ₹160 per equity share.
Natural Capsules Limited
Natural Capsules Limited held its 33rd Annual General Meeting on August 12, 2026, through video conferencing. The meeting was chaired by Tekkar Yashwanth Prabhu, and the company's Managing Director, Sunil L Mundra, made opening remarks. The meeting transacted six business items, including the adoption of audited financial statements and the re-appointment of directors. Members were given the opportunity to ask questions and seek clarifications.
Natural Capsules Limited
Natural Capsules Limited has informed about the approval of the allotment of 9,46,305 equity shares of face value of ₹10 each for cash at par, aggregating to ₹ 94,63,050. This is under Regulation 30(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Natural Capsules Limited
Natural Capsules Limited has informed about a dilution of 2.18% in its equity stake in subsidiary company Natural Biogenex Private Limited due to non-participation in a Rights Issue.
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange about the completion of dispatch of Notice of 33rd Annual General Meeting and Annual Report for FY 2025-26 through newspaper publication.
Natural Capsules Limited
Natural Capsules Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2026, to transact various business including appointment of directors, re-appointment of a whole-time director, and approval of related party transactions.